MedTrace Logo

Artificial Intelligence Performance in Colonoscopy in Daily Practice

NCT04837599 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100

Last updated 2021-04-19

No results posted yet for this study

Summary

randomized, controlled single center, single investigator study mainly in colorectal screening population in daily practice with and without artificial intelliegence (AI) named DiscoveryTM from Pentax medical. Patient randomly are allocated to one of four groups: Pentax i10 colonoscopes without any additional device, Pentax i 10 with DiscoveryTM (AI), Pentax i 10 with EndocuffTM and Pentax i10 with EndocuffTM and DiscoveryTM (AI).

The different groups are compared in terms of the different parameters: e.g. time of endoscopy, polyps (PDR) and adenoma detected (ADR).

Conditions

  • Colonic Polyp
  • Adenoma

Interventions

DEVICE

Discovery TM of Pentax medical on/off in colonoscopy

on the monitor artificial integlligence Discovery can be switched on or off.

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Gastroenterologie Baden-Wettingen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-07-31
Completion
2022-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04837599 on ClinicalTrials.gov